DISPOSITION OF SCH 10595 IN ANIMALS AND MANSYMCHOWICZ S; STAUB M.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 191; NO 2; PP. 324-330; BIBL. 19REF.Article

EFFECT OF DEXAMETHASONE ON MONOAMINE OXIDASE INHIBITION BY IPRONIAZID IN RAT BRAIN.VEALS JW; KORDUBA CA; SYMCHOWICZ S et al.1977; EUROP. J. PHARMACOL.; NETHERL.; DA. 1977; VOL. 41; NO 3; PP. 291-299; BIBL. 1 P.Article

OXIDATIVE DEMETHYLATION OF ¹⁴C-GRISEOFULVIN BY LIVER MICROSOMES OF RATS AND MICE = LA DEMETHYLATION OXYDATIVE DE LA GRISEOFULVINE-¹⁴C PAR LES MICROSOMES DU FOIE DES RATS ET DES SOURISCHANG RL; SYMCHOWICZ S; CHIN CHUNG LIN et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 11; PP. 1389-1392; BIBL. 10REF.Serial Issue

THE EFFECT OF AMANTADINE ON RADIOLABELED BIOGENIC AMINES IN THE RAT BRAINSYMCHOWICZ S; KORDUBA CA; VEALS J et al.1973; EUROP. J. PHARMACOL.; NETHERL.; DA. 1973; VOL. 21; NO 2; PP. 155-160; BIBL. 23REF.Serial Issue

COMPARATIVE BIOAVAILABILITY OF D-PSEUDOEPHEDRINE FROM A CONVENTIONAL D-PSEUDOEPHEDRINE SULFATE TABLET AND FROM A REPEAT ACTION TABLETLIN C; LIM J; SYMCHOWICZ S et al.1982; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1982; VOL. 10; NO 2; PP. 126-128; BIBL. 1 REF.Article

PHARMACOKINETIC STUDY OF SISOMICIN IN HUMANSMENGER CHUNG; SCHROGIE JJ; SYMCHOWICZ S et al.1981; J. PHARMACOKINET. BIOPHARM. BIOPHARM.; ISSN 0090-466X; USA; DA. 1981; VOL. 9; NO 5; PP. 535-551; BIBL. 28 REF.Article

COMPARISON OF NETILMICIN AND GENTAMICIN PHARMACOKINETICS IN HUMANSCHUNG M; COSTELLO R; SYMCHOWICZ S et al.1980; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1980; VOL. 17; NO 2; PP. 184-187; BIBL. 11 REF.Article

BIOAVAILABILITY OF D-PSEUDOEPHEDRINE AND AZATADINE FROM A REPEAT ACTION TABLET FORMULATIONLIN C; LIM J; SYMCHOWICZ S et al.1982; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1982; VOL. 10; NO 2; PP. 122-125Article

EFFECTS OF 5-(N-BUTYL)-PICOLINAMIDE (SCH 10595), A DOPAMINE-BETA -HYDROXYLASE INHIBITOR, ON SEROTONIN AND CATECHOLAMINE METABOLITES IN BRAIN = EFFETS DE LA (N-BUTYL)-5 PICOLINAMIDE (SCH 10595), UN INHIBITEUR DE LA DOPAMINE-BETA -HYDROXYLASE, SUR LES METABOLITES DE LA SEROTONINE ET DES CATECHOLAMINES DANS LE CERVEAUKORDUBA CA; VEALS J; SYMCHOWICZ S et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 190; NO 3; PP. 459-465; BIBL. 19REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF ROSARAMICIN IN HUMANSLIN C; KIM H; SCHUESSLER D et al.1980; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1980; VOL. 18; NO 5; PP. 780-783; BIBL. 7 REF.Article

SCH 10595, AN EFFECTIVE DOPAMINE-BETA -HYDROXYLASE INHIBITOR AND A HYPOTENSIVE AGENT = LE SCH 10595, UN INHIBITEUR EFFICACE DE LA DOPAMINE-BETA -HYDROXYLASE ET UN AGENT HYPOTENSEURKORDUBA CA; VEALS J; WOHL A et al.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 184; NO 3; PP. 671-677; BIBL. 15REF.Serial Issue

COMPARATIVE BIOAVAILABILITY OF A MICROSIZE AND ULTRAMICROSIZE GRISEOFULVIN FORMULATION IN MANLIN C; LIM J; DIGIORE C et al.1982; JOURNAL OF INTERNATIONAL MEDICAL RESEARCH; ISSN 0300-0605; GBR; DA. 1982; VOL. 10; NO 4; PP. 274-277; BIBL. 2 REF.Article

THE METABOLISM OF CHLORPHENIRAMINE MALEATE IN THE DOG AND RATPEETS EA; WEINSTEIN R; BILLARD W et al.1972; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1972; VOL. 199; NO 1; PP. 172-190; BIBL. 16 REF.Serial Issue

ABSORPTION, EXCRETION AND URINARY METABOLIC PATTERN OF ³H-ALBUTEROL AEROSOL IN MANLIN C; MAGAT J; CALESNICK B et al.1972; XENOBIOTICA; G.B.; DA. 1972; VOL. 2; NO 6; PP. 507-515; BIBL. 8REF.Serial Issue

BIOAVAILABILITY OF ORALLY ADMINISTERED PROPIRAM FUMARATE IN HUMANSKORDUBA CA; VEALS J; RADWANSKI E et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 5; PP. 521-523; BIBL. 6 REF.Article

ISOLATION AND IDENTIFICATION OF THE MAJOR METABOLITE OF ALBUTEROL IN HUMAN URINE.LIN C; LI Y; MCGLOTTEN J et al.1977; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1977; VOL. 5; NO 3; PP. 234-238; BIBL. 14 REF.Article

Loratadine: multiple-dose pharmacokineticsRADWANSKI, E; HILBERT, J; SYMCHOWICZ, S et al.Journal of clinical pharmacology. 1987, Vol 27, Num 7, pp 530-533, issn 0091-2700Article

MATERNAL AND FETAL HEMODYNAMIC EFFECTS OF DIAZOXIDE. = EFFETS HEMODYNAMIQUES MATERNELS ET FOETAUX DU DIAZOXIDENUWAYHID B; BRINKMAN CR III; KATCHEN B et al.1975; OBSTETR. AND GYNECOL.; U.S.A.; DA. 1975; VOL. 46; NO 2; PP. 197-203; BIBL. 16 REF.Article

COMPARATIVE PHARMACOKINETICS OF AMINOGLYCOSIDE ANTIBIOTICS IN GUINEA PIGSCHUNG M; PARRAVICINI L; ASSAEL BM et al.1982; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1982; VOL. 22; NO 6; PP. 1017-1021; BIBL. 12 REF.Article

Single and multiple dose pharmacokinetic evaluation of flutamide in normal geriatric volunteersRADWANSKI, E; PERENTESIS, G; SYMCHOWICZ, S et al.Journal of clinical pharmacology. 1989, Vol 29, Num 6, pp 554-558, issn 0091-2700Article

The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouseHILBERT, J; PRAMANIK, B; SYMCHOWICZ, S et al.Drug metabolism and disposition. 1984, Vol 12, Num 4, pp 452-459, issn 0090-9556Article

ABSORPTION, METABOLISM, AND EXCRETION OF ¹⁴C-TOSIFEN IN THE DOG AND RAT.LIN C; FOESTER R; LIM J et al.1978; DRUG. METABOL. DISPOSIT.; U.S.A.; DA. 1978; VOL. 6; NO 1; PP. 50-58; BIBL. 10 REF.Article

MATERNAL AND FETAL HEMODYNAMIC EFFECTS OF DIAZOXIDE. = EFFETS HEMODYNAMIQUES MATERNELS ET FOETAUX DU DIAZOXIDENUWAYHID B; BRINKMAN CR III; KATCHEN B et al.1975; OBSTETR. AND GYNECOL.; U.S.A.; DA. 1975; VOL. 46; NO 2; PP. 197-203; BIBL. 16 REF.Article

Placental transfer of quazepam in miceHILBERT, J. M; NING, J; SYMCHOWICZ, S et al.Drug metabolism and disposition. 1986, Vol 14, Num 3, pp 310-312, issn 0090-9556Article

Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeysKIM, H; LOEBENBERG, D; MARCO, A et al.Antimicrobial agents and chemotherapy. 1984, Vol 26, Num 4, pp 446-449, issn 0066-4804Article